chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Pain of skin, Paraesthesia
Clinical narrative: Diarrhea; tingling/painful skin; tingling/painful skin; This is a spontaneous report from a non-contactable consumer, the patient. A 34-years-old-non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EW0172) via unspecified route of administration on 03May2021 at 12:00 (at the age of 34-years-old) as a single dose for Covid-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0153), via an unspecified route of administration on 12Apr2021 at 12:00 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021, the patient experienced diarrhoea and tingling/painful skin. The clinical outcome of diarrhoea, tingling and painful skin was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash erythematous, Rash morbilliform, Skin plaque, Urticaria
Clinical narrative: Full body morbilliform rash.; Hives started on trunk and proceeded to limbs; Hives grew together to form plaques; plaques spread over all skin, including palms and soles of feet but did not enter mucous membranes.; Entire body turned red, like a sunburn.; The hive-to-plaque transition was very itchy.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the right arm on 15Apr2021 at 12:30 (at the age of 51-year-old), as a single dose for COVID-19 immunisation. Medical history included borderline high blood pressure (HBP). Concomitant medication included varicella zoster vaccine rge (CHO) (SHINGRIX) received on 26Feb2021 for an unknown indication. The patient's past drug included possibly azithromycin (unconfirmed) also the patient previously received a first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration in the left arm on 18Mar2021 at 12:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Apr2021 at 01:00, the patient had experienced full body morbilliform rash, hives started on trunk which proceeded to limbs that grew together to form plaques which had spread over all skin, including palms and soles of feet but did not enter mucous membranes, entire body turned red like a sunburn and the hive-to-plaque transition was very itchy. The rash cleared in five days, with minor flareups over two subsequent days. Therapeutic measure was taken as the result of adverse event which included treatment with diphenhydramine. The clinical outcome of the events morbilliform rash, hives started on trunk which proceeded to limbs, plaques which had spread over all skin, including palms and soles of feet, sun burn like rash and  hive-to-plaque transition was very itchy was recovering at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Extremely swollen feet; Extremely swollen hands; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0736) via an unspecified route of administration in the right arm on 03May2021 at 09:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Patient medical history was reported as none. Patient did not take any medications in the past. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 12Apr2021 at 09:30 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 04May2021 at 04:00, on the day 2 of the second dose, the patient experienced extremely swollen feet and hands. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events extremely swollen feet and hands were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Scab, Skin weeping, Swelling of eyelid, Vaccination site mass
Clinical narrative: On 05/01/2021 (over 11 weeks from second dose) I noticed the injection site had risen to a bump with a head on it like a big mosquito bite.; On 05/01/2021 (over 11 weeks from second dose) I noticed the injection site had risen to a bump with a head on it like a big mosquito bite. This was not there previously. It itched significantly for 3 days and oozed with a crusty cap.; On 05/01/2021 (over 11 weeks from second dose) I noticed the injection site had risen to a bump with a head on it like a big mosquito bite. This was not there previously. It itched significantly for 3 days and oozed with a crusty cap.; On 05/01/2021 (over 11 weeks from second dose) I noticed the injection site had risen to a bump with a head on it like a big mosquito bite. This was not there previously. It itched significantly for 3 days and oozed with a crusty cap.; On the 3rd day my left eyelid was itching and by the end of the day it was significantly swollen.; On the 3rd day my left eyelid was itching and by the end of the day it was significantly swollen.; On 4th day injection site is just a small scab but eyelid is still significantly swollen.; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EP7534) via an unspecified route of administration in the left arm on 15Mar2021 at 10:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, (over 11 weeks from second dose) the patient noticed the injection site had risen to a bump with a head on it like a big mosquito bite. This was not there previously. It itched significantly for 3 days and on an unknown date in 2021, it oozed with a crusty cap. On the 3rd day on an unknown date in 2021, her left eyelid was itching and by the end of the day it was significantly swollen. On 4th day, on an unknown date in 2021, injection site was just a small scab but eyelid was still significantly swollen. The patient has had no exposure to mosquitos or other biting insects, and the arm location was exactly where the second Pfizer shot was administered. The clinical outcome of the events bump with a head on it like a big mosquito bite, itched significantly for 3 days, oozed with a crusty cap, eyelid was itching and significantly swollen, injection site was just a small scab was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site scab
Clinical narrative: On 05/01/2021 (over 11 weeks from second dose) I noticed the injection site had risen to a bump with a head on it like a big mosquito bite.; On 05/01/2021 (over 11 weeks from second dose) I noticed the injection site had risen to a bump with a head on it like a big mosquito bite. This was not there previously. It itched significantly for 3 days and oozed with a crusty cap.; On 05/01/2021 (over 11 weeks from second dose) I noticed the injection site had risen to a bump with a head on it like a big mosquito bite. This was not there previously. It itched significantly for 3 days and oozed with a crusty cap.; On 05/01/2021 (over 11 weeks from second dose) I noticed the injection site had risen to a bump with a head on it like a big mosquito bite. This was not there previously. It itched significantly for 3 days and oozed with a crusty cap.; On the 3rd day my left eyelid was itching and by the end of the day it was significantly swollen.; On the 3rd day my left eyelid was itching and by the end of the day it was significantly swollen.; On 4th day injection site is just a small scab but eyelid is still significantly swollen.; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EP7534) via an unspecified route of administration in the left arm on 15Mar2021 at 10:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, (over 11 weeks from second dose) the patient noticed the injection site had risen to a bump with a head on it like a big mosquito bite. This was not there previously. It itched significantly for 3 days and on an unknown date in 2021, it oozed with a crusty cap. On the 3rd day on an unknown date in 2021, her left eyelid was itching and by the end of the day it was significantly swollen. On 4th day, on an unknown date in 2021, injection site was just a small scab but eyelid was still significantly swollen. The patient has had no exposure to mosquitos or other biting insects, and the arm location was exactly where the second Pfizer shot was administered. The clinical outcome of the events bump with a head on it like a big mosquito bite, itched significantly for 3 days, oozed with a crusty cap, eyelid was itching and significantly swollen, injection site was just a small scab was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Swollen armpit a day after receiving the 2nd shot.; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01May2021 at 12:45 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included mo. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 03Apr2021 at 12:45 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021, the patient experienced a swollen armpit a day after he received the second shot. The clinical outcome of the event swollen armpit was resolving at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Limb discomfort, Myalgia, Pyrexia
Clinical narrative: Fever 38.5C; Body chills; Muscle ache; Severe pain around injection site; Inability to lift arm; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0176) via an unspecified route of administration in the left arm on 02May2021 at 15:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included aneurysm and stent in arm for blood clot. The patient had year round indoor and outdoor allergies. Concomitant medications included cetirizine (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN) and biotin (BIOTIN SOLGAR). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received shellfish, tree nuts, shellfish and first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 2613) via an unspecified route of administration in the left arm on 11Apr2021 at 12:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 02May2021, the patient experienced fever 38.5 centigrade, body chills, muscle ache, severe pain around injection site with inability to lift arm. The clinical outcome of the event ever 38.5 centigrade, body chills, muscle ache and severe pain around injection site with inability to lift arm were resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Fever 38.5C; Body chills; Muscle ache; Severe pain around injection site; Inability to lift arm; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0176) via an unspecified route of administration in the left arm on 02May2021 at 15:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included aneurysm and stent in arm for blood clot. The patient had year round indoor and outdoor allergies. Concomitant medications included cetirizine (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN) and biotin (BIOTIN SOLGAR). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received shellfish, tree nuts, shellfish and first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 2613) via an unspecified route of administration in the left arm on 11Apr2021 at 12:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 02May2021, the patient experienced fever 38.5 centigrade, body chills, muscle ache, severe pain around injection site with inability to lift arm. The clinical outcome of the event ever 38.5 centigrade, body chills, muscle ache and severe pain around injection site with inability to lift arm were resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus symptoms began 1 day after first dose of the vaccine.  Never had this before the vaccine.  Sounds like mosquitos buzzing in the background.  very soft at first but is getting a bit louder now; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6198) via an unspecified route of administration in the arm left on 27Feb2021 at 10:30(at the age of 68-years-old) and received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number:  EP7534) via an unspecified route of administration in the arm left on 20Mar2021 at 10:15(at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included colon cancer and gastric bypass. Concomitant medications included vitamin supplements(unspecified). The patient previously took oxycodone, paracetamol(PERCOCET) from unknown date to an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 01Mar2021, the patient experienced tinnitus. The patient reported that the tinnitus symptoms began 1 day after first dose of the vaccine. She never had this before the vaccine and it sounded like mosquitos buzzing in the background. The sound was very soft at first but was getting a bit louder at the time of report. The clinical outcome of the event tinnitus was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Hot flush, Myalgia
Clinical narrative: About 15 hours after receiving shot number two, I woke up to severe chills.; hot flashes; feeling feverish; muscle ache; skin hurt to touch; lack of energy; exhausted with chills; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736), via an unspecified route of administration on 29Apr2021(at the age of 34-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient's past drug history included shellfish and sulfamethoxazole, trimethoprim (BACTRIM) for an unknown indication and also the patient previously took first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735), via an unspecified route of administration on 08Apr2021(at the age of 34-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Apr2021 at 03:00 fifteen hours after vaccination, the patient experienced chills and were off and on for the next day. On an unknown date in 2021, the patient experienced hot flashes when the chills subsided, felt feverish, muscle aches, skin hurt to be touched and felt better the following day later onto the evening. On an unknown date in 2021 the next day, the patient experienced  lack of energy and exhausted with chills coming on once in a great while. The clinical outcome of the event chills, hot flashes, feverish, muscle ache, skin hurt to touch, lack of energy, exhausted with chills were recovering at the time of this report.       .   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pain of skin, Pyrexia
Clinical narrative: About 15 hours after receiving shot number two, I woke up to severe chills.; hot flashes; feeling feverish; muscle ache; skin hurt to touch; lack of energy; exhausted with chills; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736), via an unspecified route of administration on 29Apr2021(at the age of 34-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient's past drug history included shellfish and sulfamethoxazole, trimethoprim (BACTRIM) for an unknown indication and also the patient previously took first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735), via an unspecified route of administration on 08Apr2021(at the age of 34-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Apr2021 at 03:00 fifteen hours after vaccination, the patient experienced chills and were off and on for the next day. On an unknown date in 2021, the patient experienced hot flashes when the chills subsided, felt feverish, muscle aches, skin hurt to be touched and felt better the following day later onto the evening. On an unknown date in 2021 the next day, the patient experienced  lack of energy and exhausted with chills coming on once in a great while. The clinical outcome of the event chills, hot flashes, feverish, muscle ache, skin hurt to touch, lack of energy, exhausted with chills were recovering at the time of this report.       .   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Joint swelling, X-ray
Clinical narrative: Golf ball size knot on the right ankle, same side the shot was given; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03May2021 at 14:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medication included diazepam (DIAZEPAM) taken for an unknown indication from an unknown date. The patient had no past drug history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 03May2021 at 19:00, the patient experienced a golf ball size knot on the right ankle, the same side the shot was given on. The event resulted in emergency room/department or urgent care. The patient underwent an X-ray procedure on an unspecified date in May2021, the result of which was unknown. The clinical outcome of the event golf ball size knot on the right ankle was not resolved at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain
Clinical narrative: My neck and top of shoulder has been hurting every since I took the Pfizer vaccine.; My neck and top of shoulder has been hurting every since I took the Pfizer vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Apr2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient's past drug history was reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced neck pain and shoulder pain. The patient neck and top of shoulder was hurting since Pfizer vaccine. The patient had severe neck pain and still had severe neck and shoulder pain at the time of reporting. The event resulted in doctor or other healthcare professional office/clinic visit. The doctor stated this was probably because of allergy to the protein that was injected from the vaccine. The clinical outcome of the event neck pain and shoulder pain were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Fatigue, Migraine, Myalgia
Clinical narrative: This is a spontaneous report from a contactable pharmacist. A 25-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 16Apr2021(at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included lupus and asthma. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via intramuscular route of administration on 26Mar2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the COVID vaccine. On 16Apr2021, the patient experienced bad fatigue, migraine headache, muscle pain, joint pain, body aches and upset stomach. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fatigue, migraine headache, muscle, joint pain, body aches and upset stomach was recovered on any unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: This is a spontaneous report from a contactable pharmacist. A 25-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 16Apr2021(at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included lupus and asthma. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via intramuscular route of administration on 26Mar2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the COVID vaccine. On 16Apr2021, the patient experienced bad fatigue, migraine headache, muscle pain, joint pain, body aches and upset stomach. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fatigue, migraine headache, muscle, joint pain, body aches and upset stomach was recovered on any unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Chills, Fatigue, Migraine
Clinical narrative: Bad fatigue; migraine headache; muscle and joint pain; muscle and joint pain; body aches; upset stomach; fever; chills; This is a spontaneous report from a contactable pharmacist. A 25-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration on 16Apr2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration on 26Mar2021 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Apr2021, the patient experienced bad fatigue, migraine headache, muscle and joint pain, body aches, upset stomach, fever and chills. The clinical outcome of the events bad fatigue, migraine headache, muscle and joint pain, body aches, upset stomach, fever and chills was recovered on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pyrexia
Clinical narrative: Bad fatigue; migraine headache; muscle and joint pain; muscle and joint pain; body aches; upset stomach; fever; chills; This is a spontaneous report from a contactable pharmacist. A 25-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration on 16Apr2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration on 26Mar2021 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Apr2021, the patient experienced bad fatigue, migraine headache, muscle and joint pain, body aches, upset stomach, fever and chills. The clinical outcome of the events bad fatigue, migraine headache, muscle and joint pain, body aches, upset stomach, fever and chills was recovered on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dysstasia, Gait inability, Headache, Vaccination site pain
Clinical narrative: Severe headache; Soreness at the injection site; Could not stand, walk, or get out of bed; Could not stand, walk, or get out of bed; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: Unknown) via an unspecified route of administration in the left arm on 28Apr2021 at 11:45 (at the age of 57-years-old) as a single dose for COVID -19 immunisation. Medical history included bipolar disorder, possible neuropathy. The patient had known allergies to sulpha drugs. The patient received unspecified medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: Unknown), via an unspecified route of administration in the left arm on 07Apr2021 at 11:45 (at the age of 57-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Apr2021 at 08:00, the patient could not stand, walk, or get out of bed. Shot received around Noon on 28Apr. The patient had to be carried to and from bathroom etc until 30Apr2021 around 18:00. Additionally the patient had a severe headache and soreness at the injection site. The reaction was horrible and she was fully incapacitated. The clinical outcomes of could not stand, walk, or get out of bed was recovered on 30Apr2021 at 18:00 and severe headache, soreness at the injection site were recovered on an unknown date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Mechanical urticaria, Pruritus, Swelling face, Urticaria
Clinical narrative: experienced an auto immune reaction in the form of a flare up regarding my dermatographia.; progressively worse hives; itching; swelling at face; swelling at lips; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151), via an unspecified route of administration in the left arm on 22Apr2021 at 15:15(at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history included sports induced asthma, depersonalization/derealization disorder and dermatographia. Concomitant medications included desvenlafaxine succinate monohydrate (PRISTIQ), topiramate (TOPAMAX), cetirizine hydrochloride (ZYRTEC) and vitamin d (MANUFACTURER UNKNOWN) from an unknown date and for an unknown indication. The patient had a history of allergy to sulfa drugs. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150), via an unspecified route of administration in the left arm on 01Apr2021 at 15:15 (at the age of 22-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Apr2021, the patient experienced an auto immune reaction in the form of a flare up regarding dermatographia, progressively worse hives, itching, and swelling in the face and lips. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events which included treatment with prednisone, ALLEGRA, BENADRYL and PEPCID. The clinical outcome of the events an auto immune reaction in the form of a flare up regarding dermatographia, progressively worse hives, itching and swelling in the face and lips was not resolved at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in legs worse at night; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 03Mar2021 at 13:00 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included deep vein thrombosis (DVT) on an unknown date in 2012, mitral valve repair (Heart ring mitral valve), allergy to shellfish and hazel nut.  Concomitant medications included rivaroxaban (XARELTO), metoprolol (MANUFACTURER UNKNOWN) and ezetimibe (ZETIA),all from unknown dates taken for unknown indications. The patient previously took gadolinium (MANUFACTURER UNKNOWN) for unknown indication from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Mar2021 at 07:00 ,the patient experienced pain in legs, which was worse at night. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event pain in legs was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Lip pain, Paraesthesia oral
Clinical narrative: Tingling of lips; Tingling of tongue; Numb like feeling in tongue; Sensitive lips; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736), via an unspecified route of administration in the left arm on 04May2021 at 10:00 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history included endometriosis, penicillin allergy, shellfish allergy and food allergy (ginger). Concomitant medication included cimetidine (TAGAMET) from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737), via an unspecified route of administration in the left arm on 16Apr2021 at 13:30 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. The patient previously taken erythromycin (MANUFACTURER UNKNOWN), FLAGYL and clindamycin (MANUFACTURER UNKNOWN); all for unspecified indications on unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 at 10:30, the patient experienced tingling of lips and tongue, then numb like feeling in tongue followed but sensitive lips which began 30 minutes after vaccination. The clinical outcome of the events tingling of lips and tongue, numb like feeling in tongue and sensitive lips were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Pruritus
Clinical narrative: small blisters; itch all over my body; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 18Apr2021 at 11:15 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic bronchitis on an unspecified date. Concomitant medications included vitamin d nos (VITAMIN D), zinc (MANUFACTURER UNKNOWN), acetylcysteine (N-ACETYL-L-CYSTEINE), cannabidiol (MANUFACTURER UNKNOWN) all from an unknown date for an unspecified indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 19Mar2021 at 17:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 08:00 the patient experienced small blisters that itch all over her body. The clinical outcome of the events blister, itching was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Muscle strength abnormal, Pain in extremity
Clinical narrative: Felt like don't have any strength in it; Entire left arm felt numb for a whole day, so as left leg; Soreness on left arm; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 01May2021 at 11:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient had no medical and drug history.  The patient did not receive any other medications within 2 weeks of vaccination: Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. The patient took the vaccination on Saturday 01May2021 and everything was fine other than soreness on left arm. On 03May2021, day 3 Monday entire left arm felt numb for a whole day, so as left leg and felt like don't have any strength in it. The patient forced herself to continue normal routine. Patient used a hot water bag as treatment to stimulate muscles and went away by day 4. The clinical outcome of the events soreness on left arm and entire left arm felt numb for a whole day, so as left leg was recovered on an unknown date in May2021 and felt like don't have any strength in it was recovered on 04May2021.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain, Vaccination site pruritus, Vaccination site scab
Clinical narrative: soreness at the injection site; itchiness at the injection site; scabbing at the injection site; Aching of left arm; This is a spontaneous report from a contactable consumer, the patient. A 55-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: Unknown,) via an unspecified route of administration, in the left arm on 31Mar2021 at 15:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included diastolic heart failure.  The patient previously received PERCODAN, morphine (MANUFRATURER UNKNOWN) and GEODAN on unknown date and for unspecified indication. Concomitant medications included pramipexole (MANUFRATURER UNKNOWN), carvedilol (MANUFRATURER UNKNOWN), topiramate (TOPAMAX) and erenumab (AIMOVIG) all from unknown date and for unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: Unknown) via an unspecified route of administration in the right arm on 03Mar2021 at 15:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 01Apr2021, the patient experienced soreness, itchiness, and scabbing at the injection site, aching of left arm which was persisting over a month. The clinical outcome of the events soreness, itchiness, and scabbing at the injection site, aching of left arm were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chills, Fatigue, Nausea, Pruritus
Clinical narrative: Burning feeling on upper arms and face; Nausea; Vomiting; Chills; Exhaustion; itchy on upper arms and face; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the arm left on 04May2021 at 08:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not take any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 04May2021 at 09:15, the patient experienced nausea, vomiting, chills, itchy/burning feeling on upper arms and face, exhaustion. The clinical outcomes of nausea, vomiting, chills, itchy/burning feeling on upper arms and face, exhaustion were recovering.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Burning feeling on upper arms and face; Nausea; Vomiting; Chills; Exhaustion; itchy on upper arms and face; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the arm left on 04May2021 at 08:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not take any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 04May2021 at 09:15, the patient experienced nausea, vomiting, chills, itchy/burning feeling on upper arms and face, exhaustion. The clinical outcomes of nausea, vomiting, chills, itchy/burning feeling on upper arms and face, exhaustion were recovering.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Loss of hair in large patches, two this far. Completely bald spots; This is a spontaneous report from a contactable consumer. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included zolpidem tartrate (AMBIEN) received within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 24Apr2021, the patient experienced loss of hair in large patches and there was two patches which were completely bald at the time of report. The clinical outcome of the event loss of hair in large patches and there was two patches which were completely bald was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain, SARS-CoV-2 test
Clinical narrative: Felt extreme soreness in both shoulders; Radiating down to my arms, elbow, joint areas / radiating  pain in the shoulder and elbow joints.; This is a spontaneous report from a contactable healthcare professional, the patient. A 64-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 04Jan2021 at 12:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Jan2021 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and reported as otherwise in good health. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN), vitamin D nos (MANUFACTURER UNKNOWN) and fish oil (MANUFACTURER UNKNOWN), all taken for unknown indications from unknown dates. The patient previously took bactrim and sulfur drug and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Jan2021, the patient experienced extreme soreness in both shoulders radiating down to arm, elbow, joint areas. It had been over three months since those shots, and she continued to have radiating pain in both shoulder and elbow joint areas. She had a full physical about two weeks ago from the time of this report and was in good health, except for the radiating pain in the shoulder and elbow joints. On 01May2021, the patient underwent COVID test (nasal swab) and the result was negative. The clinical outcome of the events extreme soreness in both shoulders radiating down to arm, elbow, joint areas were not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.